Tumour‐targeting bacteria‐based cancer therapies for increased specificity and improved outcome. Issue 5 (3rd August 2017)

• Record Type: Journal Article
• Authors: Felgner, Sebastian; Pawar, Vinay; Kocijancic, Dino; Erhardt, Marc; Weiss, Siegfried
• Other Names: Morgenroth Eberhard guestEditor.; Flemming Hans‐Curt guestEditor.; Azeredo Joana guestEditor.; Melo Luis F. guestEditor.; Espinosa Manuel guestEditor.; Whiteley Marvin guestEditor.; Briandet Romain guestEditor.
• Is Part Of: Microbial biotechnology. Volume 10:Issue 5(2017:Sep.)
• Page Start: 1074
• Page End: 1078
• Publication Date: 2017-08-03
• Subjects: Microbial biotechnology -- Periodicals; Biotechnology; Microbiology; 660.62
• DOI: 10.1111/1751-7915.12787
• Languages: English
• ISSNs: 1751-7915

Abstract

Abstract : 'You have cancer' – a devastating diagnosis that still strikes patients hard. Despite substantial improvements of standard therapies over the years, there is still no general cure available. Here, we review the revival of an old concept – the use of bacteria as cancer therapeutics. Bacteria‐mediated tumor therapy has great potential to evolve into a powerful tool against malignant solid tumors.